GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Enterprises Ltd (BOM:543444) » Definitions » EBIT

Fabino Enterprises (BOM:543444) EBIT : ₹0.5 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Fabino Enterprises EBIT?

Fabino Enterprises's earnings before interest and taxes (EBIT) for the six months ended in Sep. 2024 was ₹1.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ₹0.5 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Fabino Enterprises's annualized ROC % for the quarter that ended in Sep. 2024 was -0.18%. Fabino Enterprises's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 3.99%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Fabino Enterprises's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 0.52%.


Fabino Enterprises EBIT Historical Data

The historical data trend for Fabino Enterprises's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Enterprises EBIT Chart

Fabino Enterprises Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBIT
Get a 7-Day Free Trial 3.01 0.49 0.72 0.21 0.70

Fabino Enterprises Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
EBIT Get a 7-Day Free Trial Premium Member Only 0.13 0.09 1.22 -0.53 0.99

Competitive Comparison of Fabino Enterprises's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Enterprises's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fabino Enterprises's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Enterprises's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fabino Enterprises's EV-to-EBIT falls into.



Fabino Enterprises EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fabino Enterprises  (BOM:543444) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Fabino Enterprises's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

ROC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=-0.146 * ( 1 - 26.26% )/( (54.259 + 66.255)/ 2 )
=-0.1076604/60.257
=-0.18 %

where

Note: The Operating Income data used here is two times the semi-annual (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Fabino Enterprises's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2024  Q: Sep. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=1.988/( ( (3.427 + max(49.69, 0)) + (3.284 + max(43.267, 0)) )/ 2 )
=1.988/( ( 53.117 + 46.551 )/ 2 )
=1.988/49.834
=3.99 %

where Working Capital is:

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(126.119 + 13.346 + 9.211) - (98.689 + 0 + 0.29700000000001)
=49.69

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(144.647 + 34.486 + 0) - (135.293 + 0 + 0.57300000000001)
=43.267

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Fabino Enterprises's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2024 )
=0.467/89.766
=0.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fabino Enterprises EBIT Related Terms

Thank you for viewing the detailed overview of Fabino Enterprises's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Fabino Enterprises Business Description

Traded in Other Exchanges
N/A
Address
Murthal Road, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Fabino Enterprises Ltd formerly known as Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Enterprises Headlines

No Headlines